CoChat

1,2,4-Triazolo[1,5-a]pyrimidines as a Novel Class of Inhibitors of the HIV-1 Reverse Transcriptase-Associated Ribonuclease H Activity

Open access

The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.

Abstract

Despite great efforts have been made in the prevention and therapy of human immunodeficiency virus (HIV-1) infection, however the difficulty to eradicate latent viral reservoirs together with the emergence of multi-drug-resistant strains require the search for innovative agents, possibly exploiting novel mechanisms of action. In this context, the HIV-1 reverse transcriptase (RT)-associated ribonuclease H (RNase H), which is one of the few HIV-1 encoded enzymatic function still not targeted by any current drug, can be considered as an appealing target. In this work, we repurposed in-house anti-influenza derivatives based on the 1,2,4-triazolo[1,5-a]-pyrimidine (TZP) scaffold for their ability to inhibit HIV-1 RNase H function. Based on the results, a successive multi-step structural exploration around the TZP core was performed leading to identify catechol derivatives that inhibited RNase H in the low micromolar range without showing RT-associated polymerase inhibitory activity. The antiviral evaluation of the compounds in the MT4 cells showed any activity against HIV-1 (IIIB strain). Molecular modelling and mutagenesis analysis suggested key interactions with an unexplored allosteric site providing insights for the future optimization of this class of RNase H inhibitors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules25051183

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Co-crystal structure of compound 1 (magenta) bound to HIV-1 RT (PDB ID: 2I5J) [17]. Chemical structures of the allosteric RNHIs 1 [17], 2 [18], 3 [19,20], 4 [21], 5 [22,24], 6 [23,24], 7 [25], 8 [27], 9 [28], and 10 [29] reported so far and their predicted allosteric binding sites are also indicated. The IC50 value represents the compound concentration that reduces the HIV-1 RT-associated RNase H activity by 50% (HIV-1 RNase H) or the HIV-1 RT-associated RDDP activity by 50% (HIV-1 RDDP); the EC50 value represents the compound concentration that inhibits HIV-1 replication by 50%; The CC50 value represents the compound concentration that inhibits cell growth by 50%; n.d. indicates not determined value. Yellow spheres, polymerase catalytic site; red spheres, RNase H catalytic site.
Figure 1 Co-crystal structure of compound 1 (magenta) bound to HIV-1 RT (PDB ID: 2I5J) [17]. Chemical structures of the allosteric RNHIs 1 [17], 2 [18], 3 [19,20], 4 [21], 5 [22,24], 6 [23,24], 7 [25], 8 [27], 9 [28], and 10 [29] reported so far and their predicted allosteric binding sites are also indicated. The IC50 value represents the compound concentration that reduces the HIV-1 RT-associated RNase H activity by 50% (HIV-1 RNase H) or the HIV-1 RT-associated RDDP activity by 50% (HIV-1 RDDP); the EC50 value represents the compound concentration that inhibits HIV-1 replication by 50%; The CC50 value represents the compound concentration that inhibits cell growth by 50%; n.d. indicates not determined value. Yellow spheres, polymerase catalytic site; red spheres, RNase H catalytic site.CC BY · PubMed Central
Scheme 1 Synthetic routes to compounds 12b–g, 13c-g, 14b–g, 15g, 17h, and 16hh.
Scheme 1 Synthetic routes to compounds 12b–g, 13c-g, 14b–g, 15g, 17h, and 16hh.CC BY · PubMed Central
Scheme 2 Synthetic routes to compounds 18g and 19g.
Scheme 2 Synthetic routes to compounds 18g and 19g.CC BY · PubMed Central
Figure 2 (A) Catalytic center of the RNase H domain. Residues involved in the protein-duplex stabilization and surrounding the catalytic center are highlighted in stick. (B) Position of the FTMap identified pockets. Green sticks, Site1 probes; orange sticks, Site2 probes; magenta spheres, Mg2+ ions; white cartoon, p66; wheat cartoon, p55; yellow cartoon, DNA:DNA duplex. The figure was obtained using the 3LP1 structure. The DNA duplex coordinates were retrivied from 5J2M crystal structure.
Figure 2 (A) Catalytic center of the RNase H domain. Residues involved in the protein-duplex stabilization and surrounding the catalytic center are highlighted in stick. (B) Position of the FTMap identified pockets. Green sticks, Site1 probes; orange sticks, Site2 probes; magenta spheres, Mg2+ ions; white cartoon, p66; wheat cartoon, p55; yellow cartoon, DNA:DNA duplex. The figure was obtained using the 3LP1 structure. The DNA duplex coordinates were retrivied from 5J2M crystal structure.CC BY · PubMed Central
Figure 3 Overlap between FTMap probes (stick representation) and subpockets identified by DogSiteScorer (dots representation) using 3LP1, 4IF7 and 5K14 Site1 conformations. sSc: Site Score; dSc: Drug Score. Volume is expressed in Å.
Figure 3 Overlap between FTMap probes (stick representation) and subpockets identified by DogSiteScorer (dots representation) using 3LP1, 4IF7 and 5K14 Site1 conformations. sSc: Site Score; dSc: Drug Score. Volume is expressed in Å.CC BY · PubMed Central
Figure 4 Superimposition of docking poses for derivatives 12g, 15g, and 18g (green) for 3LP1 and 4IF7 proteins. Magenta lines, Hs1 probes; yellow lines, Hs2 probes; red cartoon, α-helix 14.
Figure 4 Superimposition of docking poses for derivatives 12g, 15g, and 18g (green) for 3LP1 and 4IF7 proteins. Magenta lines, Hs1 probes; yellow lines, Hs2 probes; red cartoon, α-helix 14.CC BY · PubMed Central
Figure 5 2D and 3D representation of 18g binding mode produced by docking studies on 3LP1 and 4I7F structure. Magenta lines, Hs1 probes; yellow lines, Hs2 probes; red cartoon, α-helix 14.
Figure 5 2D and 3D representation of 18g binding mode produced by docking studies on 3LP1 and 4I7F structure. Magenta lines, Hs1 probes; yellow lines, Hs2 probes; red cartoon, α-helix 14.CC BY · PubMed Central
Figure 6 (A) Superimposition of docking poses for derivatives 13g (green) and 19g (orange) in 4IF7 protein. (B) 2D and 3D representation of 13g (green) binding mode produced by docking studies on 3LP1 structure. Magenta lines, Hs1 probes; yellow lines, Hs2 probes; red cartoon, α-helix 14.
Figure 6 (A) Superimposition of docking poses for derivatives 13g (green) and 19g (orange) in 4IF7 protein. (B) 2D and 3D representation of 13g (green) binding mode produced by docking studies on 3LP1 structure. Magenta lines, Hs1 probes; yellow lines, Hs2 probes; red cartoon, α-helix 14.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Cited by

See all 30

Metadata

Authors
Desantis, J., Massari, S., Corona, A., Astolfi, A., Sabatini, S., Manfroni, G., Palazzotti, D., Cecchetti, V., Pannecouque, C., Tramontano, E., & Tabarrini, O.
Affiliations
  • University of Perugia (IT)
  • University of Cagliari (IT)
  • Rega Institute for Medical Research (BE)
Corresponding author
Tabarrini, Oriana
Venue
Molecules
Publisher
MDPI AG
Published
2020-03-05
Volume
25
Issue
5
Pages
1183
ISSN
1420-3049 (ISSN-L)
OpenAlex
W3009905010
Cited by
29
References
55
Citations by year
2026: 2 · 2025: 2 · 2024: 4 · 2023: 6 · 2022: 6 · 2021: 6 · 2020: 3
FWCI
0.72
Type
journal article
Language
en
Open access
Locations
  • Molecules (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion, other-oa)
  • Lirias (KU Leuven) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Keywords
1,2,4-triazolo[1,5-a]pyrimidines, RNase H inhibitors, antiviral drug repurposing, catechol derivatives, allosteric inhibition, MT-4 cells, molecular modeling, mutagenesis
MeSH terms
Binding Sites, Enzyme Activation, Humans, Molecular Conformation, Protein Binding, Pyrimidines, Structure-Activity Relationship, Drug Design, Molecular Structure, Ribonuclease H, Reverse Transcriptase Inhibitors, HIV Reverse Transcriptase, Molecular Dynamics Simulation, Molecular Docking Simulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 1,2,4-Triazolo[1,5-a]pyrimidines as a Novel Class of Inhibitors of the HIV-1 Reverse Transcriptase-Associated Ribonuclease H Activity. https://app.cochat.ai/papers/10.3390/molecules25051183
The paper
Desantis, J., Massari, S., Corona, A., Astolfi, A., Sabatini, S., Manfroni, G., Palazzotti, D., Cecchetti, V., Pannecouque, C., Tramontano, E., & Tabarrini, O. (2020). 1,2,4-Triazolo[1,5-a]pyrimidines as a Novel Class of Inhibitors of the HIV-1 Reverse Transcriptase-Associated Ribonuclease H Activity. Molecules. https://doi.org/10.3390/molecules25051183

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.